title: Oral Propranolol as an Alternative Therapy for Orbital Angiolymphoid Hyperplasia With Eosinophilia.
abstract: An 8-year-old female patient presented with left upper eyelid swelling and erythema. Magnetic resonance imaging revealed an orbital mass involving the left lacrimal gland with subsequent incisional biopsy leading to the diagnosis of angiolymphoid hyperplasia with eosinophilia. Initially prescribed an oral corticosteroid, alternative management was sought after 4 months due to unwanted side effects of steroid therapy. Oral propranolol (2 mg/kg/day) was initiated with concurrent steroid taper. Interval decrease in lesion size was observed on subsequent magnetic resonance imaging with complete resolution of subjective symptoms (Fig. 1). She remains stable 14 months after starting beta-blocker therapy. To our knowledge, our case is the second case report suggesting oral beta-blocker may be an alternative therapy for orbital angiolymphoid hyperplasia with eosinophilia.
authors.affiliation: Department of Ophthalmology, Wake Forest Baptist Medical Center, Winston Salem, North Carolina, U.S.A.
authors.forename: Elysa A
authors.initials: EA
authors.lastname: McClintic
authors.forename: Andrew
authors.initials: A
authors.lastname: Ting
authors.forename: R Patrick
authors.initials: RP
authors.lastname: Yeatts
mesh_terms: D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000796:Angiolymphoid Hyperplasia with Eosinophilia / Q000175:diagnosis / Q000188:drug therapy*; D001706:Biopsy; D002648:Child; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D009916:Orbital Diseases / Q000175:diagnosis / Q000188:drug therapy*; D011433:Propranolol / Q000008:administration & dosage*
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol